Clinical Trials List
2009-09-07 - 2012-01-22
Phase III
Terminated6
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Jia-Horng Kao Division of General Internal Medicine
- 蔡偉 Division of General Internal Medicine
- Chien-Hung Chen Division of General Internal Medicine
- 賴明陽 Division of General Internal Medicine
- Chen-Hua Liu Division of General Internal Medicine
- Chun-Jen Liu Division of General Internal Medicine
- 陳裕芳 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yi-Cheng Chen Digestive System Department
- Chen-Chun Lin Digestive System Department
- Chun-Yen Lin Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 謝明彥 Digestive System Department
- Jee-Fu Huang Digestive System Department
- Chia-Yen Dai Digestive System Department
- Ming-Lung Yu Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 沈建亨 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
340 participants
